Nandagopal B, Sankar S, Sagadevan K, Arumugam H, Jesudason M V, Aswathaman K, Nair A
Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore, Tamil Nadu, India.
Indian J Med Microbiol. 2015 Apr-Jun;33(2):282-5. doi: 10.4103/0255-0857.153563.
Extended-spectrum beta-lactamase (ESBL) producing strains of Coliform bacilli are on the rise and present a major threat especially in India. We assessed the frequency of ESBL producers among urinary isolates from patients presenting urinary tract infections. ESBL screening was done using Double Disk Synergy Test (DDST) and confirmed using E-test and Polymerase Chain Reaction (PCR). With E-test, 92.2% were positive for ESBL. In PCR, 100% strains were positive for any of the three gene targets tested. CTX-M was positive in majority of the strains followed by TEM and SHV. Two (3.22%) strains were positive for all the three genes; 21% strains were positive for both TEM and CTX-M genes. There was no statistically significant difference in the findings of E-test and PCR testing in the determination of ESBL producers (Fisher exact test P = 0.15). The strength of agreement between them was 'fair' (k = 0.252). Continuous monitoring of ESBL producers among Indian strains is important to rationalize the antibiotic policy to be followed.
产超广谱β-内酰胺酶(ESBL)的大肠埃希菌菌株正在增加,尤其在印度构成了重大威胁。我们评估了尿路感染患者尿液分离株中产ESBL菌的频率。采用双纸片协同试验(DDST)进行ESBL筛查,并使用E-test和聚合酶链反应(PCR)进行确认。通过E-test检测,92.2%的菌株ESBL呈阳性。在PCR检测中,所检测的三个基因靶点中的任何一个,100%的菌株均呈阳性。多数菌株CTX-M呈阳性,其次是TEM和SHV。有两株(3.22%)菌株三个基因均呈阳性;21%的菌株TEM和CTX-M基因均呈阳性。在确定产ESBL菌方面,E-test和PCR检测结果无统计学显著差异(Fisher确切概率检验P = 0.15)。二者之间的一致性强度为“中等”(k = 0.252)。持续监测印度菌株中产ESBL菌对于合理制定后续抗生素政策很重要。